Stockscreener 앱 받기
2.42
2.98%
0.07
전일 마감가:
$2.35
열려 있는:
$2.29
하루 거래량:
9,618
Relative Volume:
0.13
시가총액:
$10.79M
수익:
$1.54M
순이익/손실:
$-8.87M
주가수익비율:
-0.0682
EPS:
-35.4915
순현금흐름:
$-2.74M
1주 성능:
+8.52%
1개월 성능:
+44.91%
6개월 성능:
-98.93%
1년 성능:
-99.07%
1일 변동 폭
$2.29
$2.55
1주일 범위
$2.20
$2.60
52주 변동 폭
$1.2501
$1,046.98
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
명칭
China Sxt Pharmaceuticals Inc
전화
-
주소
-
Compare SXTC vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.42 | 10.79M | 1.54M | -8.87M | -2.74M | -35.49 |
TAK
Takeda Pharmaceutical Co Adr
|
15.91 | 50.27B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.21 | 38.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.09 | 31.90B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
542.66 | 23.03B | 3.17B | 1.29B | 1.01B | 27.09 |
China Sxt Pharmaceuticals Inc 주식(SXTC)의 최신 뉴스
Enterprise value to EBITDA forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to sales forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to revenue forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to book forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to earnings forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to EBIT forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
China SXT Pharmaceuticals Inc (SXTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China SXT Pharmaceuticals Inc - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Institutional Confidence - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
China SXT Pharmaceuticals Company Profile & Introduction - Moomoo
China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why - Sahm
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
China SXT Pharmaceuticals shares surge over 25% after hours: Here's why - MSN
China SXT Pharmaceuticals Launches $100 Million ATM Equity Program with Univest Securities - The Globe and Mail
China SXT Pharmaceuticals (SXTC) launches $100M ATM offering with Univest - Stock Titan
China SXT (NASDAQ: SXTC) sets up $100M at-the-market share offering - Stock Titan
China SXT Pharmaceuticals (SXTC) Surges 7%: Potential Breakout Above ResistanceTriple MA Cross - newsline.com
China SXT Pharmaceuticals (SXTC) Slips 3% as Stock Tests Key Support LevelsLow Volume Node - newsline.com
SXTC Faces Selling Pressure: Key Levels to Watch After 7.3% DeclineStraddle Setup - newsline.com
China SXT Pharmaceuticals (SXTC) Sees Uptick Amid Support HoldingVolume Rate Change - Newser
SXTC Should I Buy - Intellectia AI
TradingKey - TradingKey
SXTC Technical Analysis | Trend, Signals & Chart Patterns | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
China SXT Pharmaceuticals Raises $3.5 Million in Offshore Private Placement - The Globe and Mail
China SXT Pharmaceuticals Inc (SXTC) - MSN
China SXT (NASDAQ: SXTC) prices $3.5M Reg S share and warrant deal - Stock Titan
MSN Money - MSN
SXTC Stock Price, Quote & Chart | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
What guidance trend China SXT (SXTC)? (Bearish Momentum) 2026-04-29Volume Breakout - newser.com
China SXT Pharmaceuticals (SXTC) Co-CEO reports indirect Class B stake - Stock Titan
China SXT Pharmaceuticals (SXTC) CFO listed as insider in Form 3 - Stock Titan
China SXT Pharmaceuticals (SXTC) director Chee Yong Lip files Form 3 - Stock Titan
Director Ji Xiaodong files Form 3 for China SXT (SXTC) - Stock Titan
Director Liu Tong Tony files Form 3 at China SXT (SXTC) - Stock Titan
Co-CEO Simon Lim listed in China SXT (SXTC) Form 3 with no trades - Stock Titan
[Form 3] China SXT Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan
China SXT (SXTC) Sector Leadership | Q1 2025: Earnings ReportCommunity Sell Signals - Xã Thanh Hà
China SXT (SXTC) Stock: Why Industry Position (Bullish Sentiment) 2026-04-22Cash Flow - Cổng thông tin điện tử tỉnh Lào Cai
China SXT (SXTC) Stock Days to Cover (Smart Money Exits) 2026-04-15Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Tây Ninh
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
China SXT Pharmaceuticals Raises $760,000 in Registered Share Offering - The Globe and Mail
China SXT Pharmaceuticals announces $760,000 share offering on Monday By Investing.com - Investing.com India
China SXT Pharmaceuticals announces $760,000 share offering on Monday - Investing.com
SXTC (NASDAQ: SXTC) sells 2M Class A shares at $0.38 for $760K - Stock Titan
China Sxt Pharmaceuticals Inc (SXTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.26%
0.13%
자본화:
|
볼륨(24시간):